RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-18.32%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$875M
AUM Growth
+$875M
(-12%)
Cap. Flow
+$65.9M
Cap. Flow
% of AUM
7.53%
Top 10 Holdings %
Top 10 Hldgs %
28.77%
Holding
95
New
7
Increased
32
Reduced
30
Closed
6
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$11.7M |
| 2 |
Centene
CNC
|
$9.22M |
| 3 |
Biogen
BIIB
|
$9.03M |
| 4 |
UnitedHealth
UNH
|
$8.82M |
| 5 |
Neurocrine Biosciences
NBIX
|
$8.53M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$10.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$7.52M |
| 3 |
Incyte
INCY
|
$7.03M |
| 4 |
Exelixis
EXEL
|
$5.95M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$5.6M |
Sector Composition
| 1 | Healthcare | 93.94% |
| 2 | Energy | 0.12% |
| 3 | Technology | 0.11% |
| 4 | Financials | 0.09% |
| 5 | Communication Services | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$661B
| $14.3M | 1.64% |
123,695
-46,305
| -27% | -$5.36M |
|
27
FibroGen
FGEN
$48.4M
| $14M | 1.6% |
301,727
+50,537
| +20% | +$2.34M |
|
|
28
Centene
CNC
$14.8B
| $13.8M | 1.58% |
120,000
+80,000
| +200% | +$9.22M |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $13.8M | 1.58% |
215,698
+35,000
| +19% | +$2.24M |
|
|
SGEN
30
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.7M | 1.57% |
242,198
+62,198
| +35% | +$3.52M |
|
31
Glaukos
GKOS
$5.42B
| $13.5M | 1.54% |
240,579
-40,700
| -14% | -$2.29M |
|
32
Boston Scientific
BSX
$159B
| $13.4M | 1.53% |
377,908
+39,940
| +12% | +$1.41M |
|
|
AGN
33
DELISTED
Allergan plc
AGN
| $13.2M | 1.51% |
98,600
+28,555
| +41% | +$3.82M |
|
|
SAGE
34
DELISTED
Sage Therapeutics
SAGE
| $13.2M | 1.5% |
137,339
+12,600
| +10% | +$1.21M |
|
35
Sangamo Therapeutics
SGMO
$161M
| $12.7M | 1.45% |
1,103,957
-93,400
| -8% | -$1.07M |
|
36
Gilead Sciences
GILD
$140B
| $11.8M | 1.35% |
188,200
-1,447
| -0.8% | -$90.5K |
|
|
BLUE
37
DELISTED
bluebird bio
BLUE
| $11.7M | 1.34% |
+117,850
| New | +$11.7M |
|
38
LivaNova
LIVN
$3.09B
| $11M | 1.26% |
120,600
+25,600
| +27% | +$2.34M |
|
39
Iovance Biotherapeutics
IOVA
$800M
| $10.7M | 1.22% |
1,205,495
-85,000
| -7% | -$752K |
|
40
Edwards Lifesciences
EW
$47.7B
| $10.2M | 1.17% |
66,585
-30,000
| -31% | -$4.6M |
|
|
AERI
41
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $10.1M | 1.16% |
280,000
+100,000
| +56% | +$3.61M |
|
|
ARRY
42
DELISTED
Array Biopharma Inc
ARRY
| $9.94M | 1.14% |
697,370
-71,000
| -9% | -$1.01M |
|
|
WBA
43
DELISTED
Walgreens Boots Alliance
WBA
| $9.91M | 1.13% |
145,000
| – | – |
|
|
MYOK
44
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $9.25M | 1.06% |
189,322
+1,050
| +0.6% | +$51.3K |
|
45
Alnylam Pharmaceuticals
ALNY
$58.6B
| $8.13M | 0.93% |
111,550
-60,400
| -35% | -$4.4M |
|
46
Xencor
XNCR
$594M
| $7.9M | 0.9% |
218,537
+8,683
| +4% | +$314K |
|
47
Cencora
COR
$57.2B
| $7.55M | 0.86% |
101,520
| – | – |
|
|
ITCI
48
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.52M | 0.86% |
659,982
+5,000
| +0.8% | +$56.9K |
|
49
MacroGenics
MGNX
$121M
| $6.89M | 0.79% |
542,186
+200,600
| +59% | +$2.55M |
|
|
IMMU
50
DELISTED
Immunomedics Inc
IMMU
| $6.85M | 0.78% |
480,330
+55,000
| +13% | +$785K |
|